首页GE9 • FRA
add
Genmab A/S
昨日收盘价
€266.70
当日价格范围
€267.20 - €274.20
年度波幅
€246.70 - €393.50
市值
191.18亿 USD
平均交易量
14.00
市盈率
-
股息率
-
主要交易所
CPH
市场资讯
财务信息
损益表
收入
净收入
(DKK) | 2024年3月info | 年同比变化 |
---|---|---|
收入 | 41.43亿 | 45.16% |
经营支出 | 31.57亿 | 30.62% |
净收入 | 13.25亿 | 486.28% |
净利润率 | 31.98 | 303.79% |
每股收益 | — | — |
息税折旧摊销前利润 | 8.61亿 | 66.22% |
有效税率 | 22.79% | — |
资产负债表
总资产
负债总额
(DKK) | 2024年3月info | 年同比变化 |
---|---|---|
现金及短期投资 | 295.84亿 | 20.53% |
总资产 | 366.80亿 | 20.68% |
负债总额 | 41.83亿 | 30.56% |
权益总额 | 324.97亿 | — |
发行在外的股份 | 6514.15万 | — |
市净率 | 0.53 | — |
资产回报率 | 5.56% | — |
资本回报率 | 6.08% | — |
现金流
现金净变动
(DKK) | 2024年3月info | 年同比变化 |
---|---|---|
净收入 | 13.25亿 | 486.28% |
来自运营的现金 | 15.13亿 | -53.23% |
投资现金 | -14.41亿 | -10,984.62% |
融资现金 | -5.95亿 | 2.62% |
现金净变动 | -1.97亿 | -108.23% |
自由现金流 | 11.50亿 | -58.69% |
简介
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan. Genmab is a dual-listed company with shares traded on both the Copenhagen Stock Exchange in Denmark and the NASDAQ Global Select Market in the US.
The company has 8 approved antibodies used in 8 marketed products, covering cancer indications and autoimmune diseases.
Proprietary, marketed with partners:
Epkinly/Tepkinly for the treatment of Relapsed/refractory diffuse large B-cell lymphoma
Tivdak for the treatment of previously treated recurrent or metastatic cervical cancer
Marketed by partners:
Darzalex (IV) / Darzalex Faspro for the treatment of all stages of multiple myeloma as combination therapy or monotherapy, and for the treatment of newly diagnosed amyloid light-chain amyloidosis
Kesimpta for the treatment of relapsing remitting multiple sclerosis
Rybrevant for the treatment of non-small-cell lung cancer Wikipedia
成立时间
2月 1999
员工数量
2,286